title: Hydrogen sulfide and sodium nitroprusside compete to activate/deactivate MMPs in bone tissue homogenates.
abstract: BACKGROUND
  Bone microvascular remodeling is the primary predictor of bone structure and function. Remodeling by its very nature implies synthesis and degradation of the extracellular matrix. Normally, 50% of total protein in the vessel wall is elastin. During remodeling, elastin is degraded by specialized matrix metalloproteinases (MMPs). Because the turnover of elastin is 1000-fold slower than that of collagen, most of the elastin is replaced by stiffer collagen. Stiffer vessels impose pressure on the aortic valve, causing regurgitation and increased pulse pressure. On the other hand, high MMP activity will cause vascular dilatation, leading to aneurysm. Therefore, balanced constitutive remodeling is necessary for adequate bone structure and function. Interestingly, collagen-degrading MMPs are involved in various pathological conditions, including osteoporosis, osteoarthritis, and cardiovascular disease. Sodium nitroprusside is a nitric oxide donor that could potentially alter MMP activity via vasodilation in vivo, but can also produce peroxynitrite, which activates MMPs by combining with superoxide. Moreover, hydrogen sulfide is a known antioxidant as well as a vasodilator, and is also speculated to contribute directly to MMP activity. We hypothesized that hydrogen sulfide reduced activity of MMP in ex vivo bone tissue homogenates and that sodium nitroprusside would increase MMP activity in vitro.
  
  
  METHODS
  We surgically removed the tibia and femur from anesthetized mice, and prepared bone tissue homogenates using a mortar and pestle, measured the protein concentration with a spectrophotometer, and detected MMP activity using gelatin gel zymography.
  
  
  RESULTS
  Our data showed increased MMP activity at a sodium nitroprusside concentration of 1 μM, and MMP activity increased exponentially. There was a decrease in MMP activity with increasing hydrogen sulfide, beginning at 16 μM (P < 0.01) and continuing to 40 μM. Moreover, sodium nitroprusside 3 μM was able to overcome the decrease in MMP activity that occurred with hydrogen sulfide 40 μM; this resulted in a more pronounced exponential increase in MMP activity.
  
  
  CONCLUSIONS
  There are several substances that can potentially be used to decrease MMP activity and to alleviate pathological remodeling by MMPs.
authors: Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY, USA.
authors: Thomas P
authors: TP
authors: Vacek
authors: Natia
authors: N
authors: Qipshidze
authors: Suresh C
authors: SC
authors: Tyagi
mesh_terms: D000818:Animals; D016723:Bone Remodeling / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D020536:Enzyme Activators / Q000494:pharmacology*; D005269:Femur / Q000187:drug effects* / Q000201:enzymology; D006862:Hydrogen Sulfide / Q000494:pharmacology*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D061965:Matrix Metalloproteinase Inhibitors / Q000494:pharmacology*; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D051379:Mice; D009599:Nitroprusside / Q000494:pharmacology*; D013053:Spectrophotometry; D013977:Tibia / Q000187:drug effects* / Q000201:enzymology
chemical_list: D020536:Enzyme Activators; D061965:Matrix Metalloproteinase Inhibitors; D009599:Nitroprusside; D020782:Matrix Metalloproteinases; D020780:Matrix Metalloproteinase 9; C501830:Mmp9 protein, mouse; D006862:Hydrogen Sulfide
keywords: bone remodeling; collagen cross-linking; homocysteine; matrix metalloproteinases; oxidative stress
references: Biochem Biophys Res Commun. 2004 Jan 9;313(2):362-8
references: 14684169
references: Antioxid Redox Signal. 2009 Jan;11(1):25-33
references: 18837652
references: Amino Acids. 2010 Nov;39(5):1161-9
references: 20352463
references: Antioxid Redox Signal. 2010 May 15;12(10):1191-202
references: 19803739
references: J Heart Valve Dis. 2002 Nov;11(6):875-80; discussion 880
references: 12479292
references: J Surg Res. 2004 Jan;116(1):70-80
references: 14732351
references: Biochem Biophys Res Commun. 2004 Jun 4;318(3):756-63
references: 15144903
references: Endothelium. 2007 Nov-Dec;14(6):315-23
references: 18080868
references: Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H451-6
references: 19933416
references: Hypertension. 2002 Jun;39(6):1088-94
references: 12052847
references: FASEB J. 2002 Nov;16(13):1792-8
references: 12409322
references: J Orthop Res. 2011 Oct;29(10):1511-6
references: 21469179
references: Physiol Rev. 1994 Jan;74(1):139-62
references: 8295932
references: J Biol Chem. 2004 Nov 19;279(47):49199-205
references: 15347670
references: Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):661-70
references: 16677109
references: J Neurooncol. 2010 Jan;96(2):201-9
references: 19629394
references: Indian J Biochem Biophys. 2009 Dec;46(6):441-6
references: 20361707
references: Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2825-35
references: 16877562
references: Int J Cardiol. 2008 Jun 6;126(3):414-20
references: 18192036
references: Muscle Nerve. 2007 Jul;36(1):1-13
references: 17410592
references: Antioxid Redox Signal. 2010 May 15;12(10):1147-54
references: 19769459
references: J Neurochem. 2004 Aug;90(3):765-8
references: 15255956
references: Endocrinology. 1998 Mar;139(3):1338-45
references: 9492070
references: Eur J Cardiothorac Surg. 2004 Aug;26(2):262-9
references: 15296881
references: Matrix Biol. 2010 Jan;29(1):3-8
references: 19765656
references: Nitric Oxide. 2007 Jun;16(4):425-32
references: 17452115
references: Biochim Biophys Acta. 1984 Nov 6;802(1):151-4
references: 6091772